O
MCK icon

OrbiMed’s McKesson MCK Stock Holding History

OrbiMed’s Portfolio MCK Stock Details MCK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-74,100
Closed -$9.83M – 145
2018
Q3 		$9.83M Buy
+74,100
New +$9.66M 0.12% 112
2016
Q3 		– Sell
-43,400
Closed -$8.1M – 146
2016
Q2 		$8.1M Sell
43,400
-33,800
-44% -$5.93M 0.08% 100
2016
Q1 		$12.1M Sell
77,200
-272,172
-78% -$44M 0.13% 83
2015
Q4 		$68.9M Sell
349,372
-350,628
-50% -$66.2M 0.62% 45
2015
Q3 		$130M Sell
700,000
-18,000
-3% -$3.82M 1.31% 24
2015
Q2 		$161M Buy
718,000
+5,000
+0.7% +$1.16M 1.35% 23
2015
Q1 		$161M Sell
713,000
-29,000
-4% -$6.43M 1.38% 27
2014
Q4 		$154M Buy
742,000
+34,000
+5% +$6.91M 1.47% 29
2014
Q3 		$138M Buy
708,000
+48,000
+7% +$9.24M 1.44% 29
2014
Q2 		$123M Buy
660,000
+81,000
+14% +$14.4M 1.44% 26
2014
Q1 		$102M Buy
579,000
+224,000
+63% +$39.1M 1.26% 25
2013
Q4 		$57.3M Buy
355,000
+279,000
+367% +$42.9M 0.84% 39
2013
Q3 		$9.75M Hold
76,000
– – 0.17% 80
2013
Q2 		$8.7M Buy
+76,000
New +$8.46M 0.18% 82

Other funds holding MCK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
VVP
Vulcan Value Partners Birmingham, Alabama $3.77B AUM 9.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed's MCK Position: Q4 2018 in Review

OrbiMed sold out of McKesson (MCK) in Q4 2018, closing a stake of 74,100 shares — an estimated $9.83M sold.

OrbiMed first reported a position in MCK in Q2 2013 and held it in 14 quarters. The position peaked at $161M in Q2 2015. 855 funds tracked by Wall St. Rank hold MCK as of Q4 2018.

  • OrbiMed reported no remaining McKesson position as of Q4 2018 after selling out during the quarter.
  • OrbiMed sold 74,100 McKesson shares in Q4 2018, an estimated $9.83M.
  • OrbiMed first reported a position in McKesson in Q2 2013 and held it in 14 quarters.
  • OrbiMed's McKesson position peaked at $161M in Q2 2015.
  • 855 funds tracked by Wall St. Rank held McKesson as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.